There are dozens of insider trades made each week, and reported to the SEC, which are then made public. Let's take a look at seven of the most important you should be paying attention to.
, Chief Financial Officer at Repros Therapeutics Inc (NASDAQ:RPRX
), bought 1,000 shares. The move came amid safety and efficiency reports from Repros about its new drug, Androxal, which is being developed for testosterone development in men.
KB Home (NYSE:KBH
) was also in the middle of two insider transactions recently. Thomas S Silk
, SVP of Marketing and Communications, acquired 5,000 shares of common stock, at a price of $6.04 apiece, with the value of the deal amounting to $30,200. Jeffrey T. Mezger
, President and CEO at KB Home, bought 150,000 shares, and Jeff Kaminski
, EVP & Chief Financial Officer, acquired 15,000 shares.
John A. Crum
, Chairman, President and CEO of Midstates Petroleum Company Inc (NYSE:MPO
), increased his position in the company by 10,000 shares, to 1.3 million total.
J Michael Ancius
, Director at Fastenal Company (NASDAQ:FAST
), now holds 6,600 shares, worth $317,130. The trades were made at a price of $47.91 per share.
A director at Century Bancorp, Inc. (NASDAQ:CNBKA
), Marshall M. Sloane
, bought 304 shares, increasing his holdings slightly.
Markel Corporation (NYSE:MKL
)'s director, D Darrell Martin
, bought 150 shares at a price of $538.30 a pop.
Three insiders at Occidental Petroleum bought in
: VP James Lienert, VP Edward Lowe and VP Controller Pineci Roy.